Despite concerns about possible side-effects as Covid-19 vaccines are rolled out around the world, evidence from the UK’s well-advanced vaccination programme suggests recipients of the leading jabs have little to fear.
The UK Medicines and Healthcare products Regulatory Agency (MHRA) operates a Yellow Card surveillance scheme, which enables health professionals and members of the public to report suspected adverse events following vaccination.
By 14 February, the UK had administered 8.3m first doses of the BioNTech/Pfizer vaccine resulting in 26,823 cards and 6.9m first doses of the Oxford/AstraZeneca jab generating 31,427 cards.
您已阅读16%（635字），剩余84%（3233字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。